chloroquine has been researched along with Androgen-Independent Prostatic Cancer in 7 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Kudo, Y | 1 |
Endo, S | 1 |
Fujita, M | 1 |
Ota, A | 1 |
Kamatari, YO | 1 |
Tanaka, Y | 1 |
Ishikawa, T | 1 |
Ikeda, H | 1 |
Okada, T | 1 |
Toyooka, N | 1 |
Fujimoto, N | 1 |
Matsunaga, T | 1 |
Ikari, A | 1 |
Lin, JZ | 1 |
Wang, WW | 1 |
Hu, TT | 1 |
Zhu, GY | 1 |
Li, LN | 1 |
Zhang, CY | 1 |
Xu, Z | 1 |
Yu, HB | 1 |
Wu, HF | 1 |
Zhu, JG | 1 |
Lin, C | 1 |
Blessing, AM | 1 |
Pulliam, TL | 1 |
Shi, Y | 1 |
Wilkenfeld, SR | 1 |
Han, JJ | 1 |
Murray, MM | 1 |
Pham, AH | 1 |
Duong, K | 1 |
Brun, SN | 1 |
Shaw, RJ | 1 |
Ittmann, MM | 1 |
Frigo, DE | 1 |
Mortezavi, A | 1 |
Salemi, S | 1 |
Kranzbühler, B | 1 |
Gross, O | 1 |
Sulser, T | 1 |
Simon, HU | 1 |
Eberli, D | 1 |
Nguyen, HG | 1 |
Yang, JC | 1 |
Kung, HJ | 1 |
Shi, XB | 1 |
Tilki, D | 1 |
Lara, PN | 1 |
DeVere White, RW | 1 |
Gao, AC | 1 |
Evans, CP | 1 |
Babcook, MA | 1 |
Sramkoski, RM | 1 |
Fujioka, H | 1 |
Daneshgari, F | 1 |
Almasan, A | 1 |
Shukla, S | 1 |
Nanavaty, RR | 1 |
Gupta, S | 1 |
Wang, L | 1 |
Wang, J | 1 |
Xiong, H | 1 |
Wu, F | 1 |
Lan, T | 1 |
Zhang, Y | 1 |
Guo, X | 1 |
Wang, H | 1 |
Saleem, M | 1 |
Jiang, C | 1 |
Lu, J | 1 |
Deng, Y | 1 |
7 other studies available for chloroquine and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
Topics: Apoptosis; Autophagy; Autophagy-Related Proteins; Cell Line, Tumor; Cysteine Endopeptidases; Humans; | 2022 |
FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
Topics: AMP-Activated Protein Kinase Kinases; Apoptosis; Autophagy; Autophagy-Related Protein 7; Beclin-1; C | 2020 |
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Calci | 2021 |
Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.
Topics: Abiraterone Acetate; Adenine; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein | 2019 |
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.
Topics: Androgen Receptor Antagonists; Animals; Autophagy; Benzamides; Cell Line, Tumor; Chloroquine; Clomip | 2014 |
Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Autophagy; Cell Line, Tumor; Chloroquine; Drug Combinations; G | 2014 |
Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.
Topics: Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cell Line, Tumor; Cell Survival | 2016 |